[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.121.0. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Letters
October 21, 1998

Report of Randomized Controlled Trials Identified in the Chinese Literature vs MEDLINE

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;280(15):1308-1309. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-15-jbk1021

To the Editor.—For systematic reviews to be comprehensive and reliable, they need to include as many as possible relevant randomized controlled trials (RCTs) in any language. Excluding RCTs from a systematic review on the basis of language of publication can lead to loss of precision1 and bias.2 Most Chinese research is published in Chinese and is therefore not accessible to the Western world. The Cochrane Stroke Group, therefore, developed collaborative links to identify RCTs in the Chinese literature and to facilitate the conduct of systematic reviews both in stroke and other fields.

First Page Preview View Large
First page PDF preview
First page PDF preview
×